Novo versus Lilly spotlights wider Europe-US corporate divide

Novo Nordisk, darling of the weight-loss boom, is trimming its own waistline. The Danish drug maker is cutting 9,000 jobs.
According to Bloomberg, it took 1,835 Novo employees to generate each $1 billion of revenue last year.
Read more...